Proctozone Gmax

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the relief of occasional constipation. It typically produces a bowel movement within 15 minutes to 1 hour after administration.

There are no teratogenic or nonteratogenic effects associated with this product.

Dosage and Administration

Tear off one suppository from the strip. If the suppository appears soft, it is recommended to place it in the refrigerator prior to use or to run cold water over it before removing the foil wrapper. Gently remove the suppository by peeling apart the wrapper.

To facilitate insertion, rub a water-based lubricant over the tip of the suppository or dip it in water. The patient should lie on their side and insert one suppository, tapered end first, approximately the length of their finger into the rectum. It is important to hold the suppository in place for about 15 to 20 minutes to allow sufficient time for it to melt.

For adults and children aged 6 years and older, the recommended dosage is one suppository administered once daily. The use of this product is not recommended for children under 6 years of age.

Contraindications

Use is contraindicated for periods exceeding one week unless directed by a healthcare professional. Prolonged use may lead to potential complications or adverse effects that require medical supervision.

Warnings and Precautions

For rectal use only. It is imperative that this product is not utilized for a duration exceeding one week unless specifically directed by a healthcare professional. Prior to use, individuals should consult a physician if they are experiencing abdominal pain, nausea, or vomiting, or if there is a sudden change in bowel habits lasting more than two weeks.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Patients are instructed to discontinue use and consult a healthcare provider if they experience rectal bleeding or if there is no bowel movement following the use of this product, as these symptoms may indicate a serious underlying condition.

Side Effects

Patients using this product may experience rectal discomfort or a burning sensation. These side effects are generally mild; however, it is important to monitor for more serious reactions.

Patients should discontinue use and consult a healthcare professional if they experience rectal bleeding or if there is no bowel movement after using the product, as these symptoms may indicate a serious underlying condition.

Additionally, patients are advised to seek medical advice prior to use if they have a history of abdominal pain, nausea, or vomiting, or if they have experienced a sudden change in bowel habits lasting more than two weeks.

This product is intended for rectal use only, and adherence to these guidelines is essential for patient safety.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Proctozone Gmax (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 years and older may receive 1 suppository once daily. The use of this medication is not recommended for children under 6 years of age.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of Proctozone-GMax (glycerin suppository) during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and therefore, the potential risks to the fetus remain unknown. Pregnant patients or those planning to become pregnant should consult a healthcare professional before use.

Use of Proctozone-GMax during pregnancy should be considered only if clearly needed, and the potential benefits must justify any potential risks to the fetus. No specific dosage modifications for pregnant women are provided; healthcare professionals should be consulted for guidance regarding use in this population.

Lactation

There are no specific warnings or considerations regarding the use of Proctozone-GMax glycerin suppositories in lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to this population, as the absence of detailed guidance necessitates careful clinical judgment regarding the use of the medication in individuals with reduced kidney function. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use this product for longer than one week unless directed by a healthcare professional. It is important to counsel patients to stop using the product and consult a doctor if they experience rectal bleeding or if they do not have a bowel movement after using the product, as these symptoms may indicate a serious condition.

While using this product, patients may experience rectal discomfort or a burning sensation. Healthcare providers should encourage patients to discuss any abdominal pain, nausea, or vomiting with them before use. Additionally, patients should be advised to seek medical advice if they notice a sudden change in bowel habits lasting more than two weeks.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a controlled environment, ensuring that it is kept away from excessive heat to maintain its integrity and efficacy. Proper storage conditions are crucial for preserving the quality of the product throughout its shelf life.

Additional Clinical Information

The route of administration for the medication is rectal. For adults and children aged 6 years and older, the recommended dosage is one suppository once daily. The use of this medication is not advised for children under 6 years of age. No further information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Proctozone Gmax, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)